Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × trebananib × Clear all

NCT01553188 2019-03-05

AMG 386 and Abiraterone for Advanced Prostate Cancer

Phase 2 Completed

36 enrolled 18 charts

Prostatic Neoplasms